CD274 and melanoma: Co-displaying MHC class I/peptide complexes and anti-CD28 antibodies, nano-aAPCs stimulated robust T cell proliferation ex vivo, generating high-affinity CTLs) capable of lysing PD-L1+ melanoma cells.